MEET OUR SPEAKERS

KEYNOTE SPEAKERS

    

A. Keith Stewart 
MBChB, FRACP (C) MBA

Professor Keith Stewart is Director of the Princess Margaret Cancer Centre and Vice President Cancer and Laboratory Medicine Program at University Health Network, Toronto.  He is the Richard H. Clark Chair in Cancer Medicine and a Professor in the Department of Medicine at the University of Toronto. In these roles he oversees all aspects of cancer care, research and education across University Health Network and has regional responsibility for cancer programs in central Toronto.

Dr Stewart’s own research and clinical practice is focused on the biology, genomics and treatment of Multiple Myeloma. He has published over 350 research papers and led numerous clinical trials of novel therapeutics for this disease from first in man to large practice changing studies. Dr Stewart has served on the advisory and medical or scientific boards of many private and public institutions including currently as a non-executive board member of Genomics England.


    

Adam Bryant

Dr Adam Bryant is a Senior Staff Specialist Haematologist at Liverpool Hospital in South Western Sydney (SWS) and a Conjoint Senior Lecturer with the University of New South Wales. He is the current President and NSW Councillor of the Haematology Society of Australia and New Zealand.

At Liverpool Hospital, Adam leads the Myeloma and Plasma Cell Disorders Unit and serves as Deputy Director of the Transplant and Cellular Therapies Unit, where he is overseeing the development of the hospital’s standard-of-care CAR-T cell program for myeloma.

Through the SWS Local Health District’s Haematology Clinical Research Unit, Adam has been Principal Investigator for numerous myeloma clinical trials, both industry-sponsored and collaborative. He is also a member of the Myeloma Working Party of the Australasian Leukaemia and Lymphoma Group and the Medical and Scientific Advisory Group (MSAG) of Myeloma Australia.


    

Peter Mollee 
MBBS(Hons), MMedSc, FRACP, FRCPA

Associate Professor Peter Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School. 

He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Netowork. 

Dr Mollee obtained a Masters in Clinical Epidemiology with a specialisation in Research Protocol Design and has a particular interest in amyloidosis and the plasma cell dyscrasias. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.